— Know what they know.
Not Investment Advice
Also trades as: 0K3W.L (LSE) · $vol 0M · MYD.DE (XETRA) · $vol 0M

MYGN NASDAQ

Myriad Genetics, Inc.
1W: +8.0% 1M: -23.0% 3M: -8.9% YTD: -36.3% 1Y: -12.1% 3Y: -79.0% 5Y: -85.7%
$3.82
-0.09 (-2.30%)
 
Weekly Expected Move ±11.2%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Strong Sell · Power 36 · $360.8M mcap · 88M float · 2.22% daily turnover · Short 23% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
56.0 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: -70.8%  ·  5Y Avg: -25.2%
Cost Advantage
63
Intangibles
76
Switching Cost
52
Network Effect
48
Scale
28
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MYGN has a Narrow competitive edge (56.0/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. Negative ROIC of -70.8% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$6
Avg Target
$7
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 22Sell: 6Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$6.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-02-24 UBS Lu Li $8 $6 -2 +27.5% $4.71
2025-11-04 UBS Lu Li $7 $8 +1 -2.2% $8.18
2025-05-07 Craig-Hallum Bill Bonello Initiated $18 +147.6% $7.27
2025-05-07 UBS Lu Li Initiated $7 -3.7% $7.27
2025-05-07 Wells Fargo Brandon Couillard $35 $6 -29 -17.5% $7.27
2025-03-12 Piper Sandler $12 $12 +1 +20.1% $10.41
2025-03-04 Piper Sandler $28 $12 -16 +10.4% $10.42
2024-12-09 Leerink Partners Puneet Souda Initiated $21 +38.6% $15.15
2024-10-14 Scotiabank Sung Ji Nam $29 $34 +5 +37.8% $24.67
2024-09-19 Morgan Stanley Tejas Savant Initiated $32 +12.4% $28.47
2024-08-27 Wells Fargo Brandon Couillard Initiated $35 +27.3% $27.50
2024-08-07 Guggenheim Subbu Nambi Initiated $29 +11.7% $25.96
2024-06-26 Scotiabank Sung Ji Nam Initiated $29 +17.8% $24.62
2024-05-13 Piper Sandler Jon Peterson $23 $28 +5 +11.7% $25.07
2023-12-21 Piper Sandler David Westenberg Initiated $23 +12.2% $20.49
2022-10-05 Stephens Mason Carrico Initiated $22 +5.7% $20.82
2022-04-19 Goldman Sachs Initiated $23 -0.1% $23.03

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MYGN receives an overall rating of C-. Strongest factors: P/B (4/5). Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

17 Grade D
Profitability
20
Balance Sheet
23
Earnings Quality
29
Growth
32
Value
40
Momentum
35
Safety
0
Cash Flow
22
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MYGN scores highest in Value (40/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-1.77
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-5.52
Unlikely Manipulator
Ohlson O-Score
-5.17
Bankruptcy prob: 0.6%
Low Risk
Credit Rating
B
Score: 27.9/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -0.01x
Accruals: -46.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MYGN scores -1.77, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MYGN scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MYGN's score of -5.52 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MYGN's implied 0.6% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MYGN receives an estimated rating of B (score: 27.9/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.90x
PEG
0.00x
P/S
0.44x
P/B
1.06x
P/FCF
-24.23x
P/OCF
175.69x
EV/EBITDA
-1.44x
EV/Revenue
0.58x
EV/EBIT
-1.25x
EV/FCF
-27.69x
Earnings Yield
-94.84%
FCF Yield
-4.13%
Shareholder Yield
0.07%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MYGN currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.036
EBT / EBIT
×
EBIT Margin
-0.466
EBIT / Rev
×
Asset Turnover
0.956
Rev / Assets
×
Equity Multiplier
1.622
Assets / Equity
=
ROE
-74.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MYGN's ROE of -74.8% is driven by Asset Turnover (0.956), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.82
Median 1Y
$2.16
5th Pctile
$0.68
95th Pctile
$6.87
Ann. Volatility
72.7%
Analyst Target
$6.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Brian J. Donnelly
Chief Commercial Officer
$350,000 $4,801,898 $6,000,145
Samraat S. Raha
President and Chief Executive Officer
$856,901 $3,989,729 $5,686,740
Mark S. Verratti
Chief Operating Officer
$622,883 $2,058,069 $3,145,251
Scott J. Leffler
Former Chief Financial Officer
$393,798 $1,067,674 $2,736,493
Margaret Ancona EVP,
er EVP, Strategy and Transformation
$330,850 $800,754 $1,895,166
Dale Muzzey, Ph.D.
Chief Scientific Officer
$506,400 $1,121,054 $1,862,912
Benjamin R. Wheeler
Chief Financial Officer
$408,493 $759,229 $1,507,897
Paul J. Diaz
Former President and Chief Executive Officer
$418,103 $— $688,637

CEO Pay Ratio

29:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $5,686,740
Avg Employee Cost (SGA/emp): $199,111
Employees: 2,700

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,700
0.0% YoY
Revenue / Employee
$305,370
Rev: $824,500,000
Profit / Employee
$-135,519
NI: $-365,900,000
SGA / Employee
$199,111
Avg labor cost proxy
R&D / Employee
$39,556
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -6.0% -2.0% -2.9% -0.9% -1.9% -8.4% -12.1% -15.8% -26.8% -29.6% -31.6% -28.1% -18.6% -13.9% -17.2% -13.7% -53.3% -54.0% -68.5% -74.8% -74.81%
ROA -4.0% -1.3% -2.0% -0.6% -1.3% -5.6% -8.9% -11.6% -19.7% -21.8% -22.5% -20.0% -13.2% -9.9% -11.7% -9.3% -36.4% -36.8% -42.2% -46.1% -46.12%
ROIC -8.3% -11.4% -20.9% -17.4% -17.1% -13.2% -10.7% -13.9% -22.2% -23.5% -25.6% -23.2% -15.5% -11.5% -13.2% -13.3% -44.6% -45.0% -71.4% -70.8% -70.75%
ROCE 0.0% 0.0% -3.9% -5.2% -6.7% -10.6% -11.5% -15.0% -24.2% -25.8% -26.2% -23.5% -15.5% -11.5% -14.0% -14.3% -48.2% -48.5% -67.1% -67.4% -67.39%
Gross Margin 71.6% 71.4% 71.5% 70.9% 72.3% 67.8% 69.7% 67.3% 68.5% 70.0% 68.7% 68.1% 69.6% 70.2% 71.7% 68.5% 71.2% 69.9% 70.0% 68.7% 68.66%
Operating Margin -11.0% -47.8% -26.8% -9.0% -9.9% -28.8% -25.9% -28.8% -62.0% -31.3% -16.0% -13.8% -17.3% -9.4% -18.5% -14.8% -1.5% -11.3% -2.7% -12.6% -12.62%
Net Margin -2.5% 14.7% -4.7% -12.4% -7.9% -22.4% -23.8% -30.2% -63.3% -31.9% -15.9% -12.9% -17.4% -10.4% -20.2% -0.1% -1.6% -13.3% -3.8% -17.0% -17.02%
EBITDA Margin 9.1% 33.2% -18.5% -1.1% -2.5% -19.4% -17.6% -18.0% -55.7% -24.0% -8.3% -4.8% -10.1% -2.3% -11.2% -7.2% -1.5% -4.8% 3.9% -8.7% -8.73%
FCF Margin -5.0% -1.3% 0.0% -17.2% -24.5% -21.6% -22.4% -22.4% -17.1% -18.8% -24.5% -20.0% -17.6% -13.0% -4.6% -4.3% -6.0% -3.2% -2.5% -2.1% -2.10%
OCF Margin -1.1% 2.7% 2.6% -14.7% -21.6% -16.5% -15.7% -13.4% -6.4% -8.7% -14.7% -12.4% -11.6% -8.5% -1.0% -0.8% -2.7% -0.3% 0.2% 0.3% 0.29%
ROE 3Y Avg snapshot only -51.03%
ROE 5Y Avg snapshot only -34.09%
ROA 3Y Avg snapshot only -28.97%
ROIC 3Y Avg snapshot only -34.14%
ROIC Economic snapshot only -53.98%
Cash ROA snapshot only 0.34%
Cash ROIC snapshot only 0.56%
CROIC snapshot only -4.06%
NOPAT Margin snapshot only -36.55%
Pretax Margin snapshot only -48.23%
R&D / Revenue snapshot only 12.83%
SGA / Revenue snapshot only 64.86%
SBC / Revenue snapshot only 3.55%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -39.74 -134.27 -81.08 -246.16 -83.00 -19.92 -10.56 -12.92 -7.63 -4.79 -6.26 -8.17 -14.28 -21.46 -9.81 -8.00 -1.24 -1.68 -1.57 -1.05 -0.895
P/S Ratio 4.65 4.97 3.19 2.96 2.17 2.33 1.74 2.72 2.71 1.79 2.19 2.48 2.76 3.02 1.49 0.98 0.59 0.82 0.70 0.51 0.435
P/B Ratio 2.68 2.99 2.28 2.09 1.51 1.59 1.34 2.13 2.14 1.48 2.10 2.45 2.83 3.18 1.78 1.16 0.70 0.96 1.56 1.15 1.061
P/FCF -92.94 -381.40 11026.20 -17.21 -8.86 -10.77 -7.78 -12.11 -15.89 -9.50 -8.95 -12.39 -15.68 -23.20 -32.53 -22.65 -9.82 -25.79 -27.45 -24.23 -24.233
P/OCF 182.75 121.17 318.77 175.69 175.688
EV/EBITDA -73.07 60.88 123.91 42.88 61.91 -19.52 -17.89 -19.44 -9.79 -6.33 -8.41 -11.05 -23.85 -48.00 -21.66 -13.28 -1.48 -1.96 -1.92 -1.44 -1.442
EV/Revenue 4.92 5.23 2.83 2.60 1.80 1.95 1.79 2.76 2.75 1.83 2.20 2.49 2.78 3.04 1.54 1.02 0.64 0.86 0.77 0.58 0.581
EV/EBIT -45.42 -30.53 -16.11 -10.89 -9.97 -12.07 -7.48 -4.90 -6.40 -8.29 -14.52 -22.02 -10.67 -6.85 -1.27 -1.70 -1.65 -1.25 -1.248
EV/FCF -98.39 -401.44 9788.70 -15.10 -7.36 -9.04 -7.98 -12.31 -16.14 -9.72 -9.01 -12.46 -15.76 -23.31 -33.51 -23.70 -10.58 -27.24 -30.33 -27.69 -27.693
Earnings Yield -2.5% -0.7% -1.2% -0.4% -1.2% -5.0% -9.5% -7.7% -13.1% -20.9% -16.0% -12.2% -7.0% -4.7% -10.2% -12.5% -80.5% -59.5% -63.8% -94.8% -94.84%
FCF Yield -1.1% -0.3% 0.0% -5.8% -11.3% -9.3% -12.9% -8.3% -6.3% -10.5% -11.2% -8.1% -6.4% -4.3% -3.1% -4.4% -10.2% -3.9% -3.6% -4.1% -4.13%
PEG Ratio snapshot only 0.003
Price/Tangible Book snapshot only 2.587
EV/OCF snapshot only 200.771
EV/Gross Profit snapshot only 0.831
Shareholder Yield snapshot only 0.07%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.67 2.67 2.37 2.37 2.37 2.37 2.00 2.00 2.00 2.00 2.01 2.01 2.01 2.01 1.82 1.82 1.82 1.82 2.49 2.49 2.486
Quick Ratio 2.48 2.48 2.30 2.30 2.30 2.30 1.85 1.85 1.85 1.85 1.87 1.87 1.87 1.87 1.65 1.65 1.65 1.65 2.26 2.26 2.257
Debt/Equity 0.33 0.33 0.10 0.10 0.10 0.10 0.16 0.16 0.16 0.16 0.19 0.19 0.19 0.19 0.20 0.20 0.20 0.20 0.57 0.57 0.570
Net Debt/Equity 0.16 0.16 -0.26 -0.26 -0.26 -0.26 0.03 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.05 0.05 0.05 0.05 0.16 0.16 0.164
Debt/Assets 0.20 0.20 0.07 0.07 0.07 0.07 0.12 0.12 0.12 0.12 0.13 0.13 0.13 0.13 0.14 0.14 0.14 0.14 0.30 0.30 0.297
Debt/EBITDA -8.45 6.35 5.84 2.23 4.71 -1.39 -2.14 -1.47 -0.74 -0.68 -0.77 -0.87 -1.63 -2.92 -2.36 -2.20 -0.39 -0.39 -0.63 -0.63 -0.628
Net Debt/EBITDA -4.04 3.04 -15.66 -5.99 -12.63 3.74 -0.44 -0.30 -0.15 -0.14 -0.06 -0.06 -0.12 -0.21 -0.64 -0.59 -0.11 -0.10 -0.18 -0.18 -0.180
Interest Coverage 0.00 0.00 -6.53 -12.89 -24.29 -42.39 -38.00 -56.75 -95.26 -94.48 -89.45 -80.21 -47.94 -37.87 -43.07 -39.94 -109.61 -61.54 -36.63 -27.97 -27.971
Equity Multiplier 1.61 1.61 1.36 1.36 1.36 1.36 1.35 1.35 1.35 1.35 1.46 1.46 1.46 1.46 1.47 1.47 1.47 1.47 1.92 1.92 1.920
Cash Ratio snapshot only 1.118
Debt Service Coverage snapshot only -24.217
Cash to Debt snapshot only 0.713
FCF to Debt snapshot only -0.083
Defensive Interval snapshot only 100.4 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.34 0.36 0.50 0.50 0.49 0.48 0.54 0.55 0.55 0.58 0.64 0.66 0.68 0.70 0.77 0.76 0.77 0.76 0.95 0.96 0.956
Inventory Turnover 5.07 5.19 9.32 9.21 9.02 9.15 11.41 12.05 12.50 12.91 11.22 11.48 11.79 12.07 10.19 10.07 9.95 9.88 8.53 8.57 8.571
Receivables Turnover 4.45 4.65 7.64 7.55 7.44 7.32 7.03 7.20 7.25 7.61 6.98 7.17 7.43 7.63 7.11 7.06 7.07 7.01 6.97 7.01 7.011
Payables Turnover 5.51 5.64 7.89 7.80 7.64 7.74 6.92 7.30 7.58 7.83 8.65 8.85 9.09 9.31 8.68 8.58 8.48 8.42 7.96 7.99 7.994
DSO 82 79 48 48 49 50 52 51 50 48 52 51 49 48 51 52 52 52 52 52 52.1 days
DIO 72 70 39 40 40 40 32 30 29 28 33 32 31 30 36 36 37 37 43 43 42.6 days
DPO 66 65 46 47 48 47 53 50 48 47 42 41 40 39 42 43 43 43 46 46 45.7 days
Cash Conversion Cycle 88 84 41 41 42 43 31 31 31 30 43 41 40 39 45 45 45 46 49 49 49.0 days
Fixed Asset Turnover snapshot only 5.073
Operating Cycle snapshot only 94.6 days
Cash Velocity snapshot only 5.541
Capital Intensity snapshot only 0.852
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue -20.5% -11.3% 71.6% 65.8% 32.4% 24.8% -1.8% 1.8% 4.0% 11.0% 11.0% 11.4% 14.8% 12.1% 11.2% 7.4% 3.8% 0.2% -1.6% -0.3% -0.28%
Net Income 70.2% 89.9% 85.4% 92.6% 70.4% -2.9% -3.1% -16.8% -13.1% -2.5% -1.4% -60.5% 37.5% 57.7% 51.7% 56.8% -1.5% -2.5% -1.9% -2.9% -2.94%
EPS 71.2% 90.7% 86.2% 92.9% 71.5% -3.0% -3.0% -16.6% -12.9% -2.5% -1.2% -45.1% 43.6% 61.9% 54.3% 57.5% -1.5% -2.4% -1.8% -2.8% -2.85%
FCF -1.5% 72.1% 1.0% -11.6% -5.5% -19.7% -761.0% -32.9% 27.7% 3.3% -21.2% 0.8% -18.5% 22.4% 79.2% 76.9% 64.6% 75.7% 45.6% 51.4% 51.40%
EBITDA 23.8% 1.7% 1.2% 1.5% 1.6% -2.5% -5.3% -3.4% -11.0% -2.2% -1.9% -76.7% 52.5% 75.5% 69.9% 63.4% -2.8% -6.0% -4.6% -4.2% -4.23%
Op. Income 53.8% 41.1% 21.2% -2.7% -45.4% 18.0% 35.1% -1.4% -65.0% -1.3% -1.1% -44.8% 39.3% 57.4% 52.1% 46.6% -1.7% -2.6% -2.1% -2.1% -2.08%
OCF Growth snapshot only 1.38%
Asset Growth snapshot only -31.24%
Equity Growth snapshot only -47.51%
Debt Growth snapshot only 49.54%
Shares Change snapshot only 2.52%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -13.3% -12.5% -5.3% -6.6% -7.6% -7.5% -5.9% -3.0% 3.1% 7.1% 23.2% 23.5% 16.5% 15.8% 6.6% 6.8% 7.4% 7.7% 6.7% 6.1% 6.07%
Revenue 5Y -7.6% -6.7% -1.7% -2.1% -2.7% -3.3% -2.8% -2.2% -2.1% -1.5% -1.5% -1.5% -1.2% -0.3% 0.6% 1.8% 5.5% 6.7% 15.4% 15.0% 15.04%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y -26.3% -47.5% -26.7% -33.8%
EBITDA 5Y -21.4% -32.8% -15.1% -26.0%
Gross Profit 3Y -15.8% -14.6% -7.5% -8.7% -9.6% -9.7% -8.2% -5.0% 1.8% 6.7% 24.0% 23.9% 15.5% 14.6% 5.9% 6.1% 6.8% 7.5% 6.6% 6.4% 6.40%
Gross Profit 5Y -9.6% -8.4% -3.4% -3.7% -4.3% -5.2% -4.7% -4.4% -4.5% -3.6% -3.6% -3.6% -3.1% -2.1% -1.0% 0.7% 5.3% 6.9% 16.3% 15.7% 15.65%
Op. Income 3Y
Op. Income 5Y
FCF 3Y -87.2%
FCF 5Y -72.4%
OCF 3Y -47.6% -44.2%
OCF 5Y -37.5% -32.6% -39.2% -39.16%
Assets 3Y 6.5% 6.5% 4.0% 4.0% -5.5% -5.5% -8.5% -8.5% -8.5% -8.5% -6.9% -6.9% -6.9% -6.9% -8.0% -8.0% -8.0% -8.0% -16.2% -16.2% -16.15%
Assets 5Y 10.0% 10.0% 8.4% 8.4% 1.5% 1.5% -0.4% -0.4% 0.4% 0.4% -0.5% -0.5% -6.0% -6.0% -8.0% -8.0% -8.0% -8.0% -13.0% -13.0% -13.01%
Equity 3Y -3.0% -3.0% 0.1% 0.1% -3.9% -3.9% -6.6% -6.6% -6.6% -6.6% -3.8% -3.8% -3.8% -3.8% -10.2% -10.2% -10.2% -10.2% -25.4% -25.4% -25.38%
Book Value 3Y -4.8% -6.5% -1.3% -2.1% -6.1% -6.7% -9.4% -9.3% -9.4% -9.5% -8.0% -9.1% -8.8% -7.3% -14.0% -14.1% -14.3% -14.4% -28.7% -28.8% -28.83%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.43 0.45 0.20 0.26 0.38 0.45 0.12 0.10 0.10 0.05 0.00 0.00 0.00 0.00 0.01 0.22 0.88 0.94 0.90 0.89 0.889
Earnings Stability 0.52 0.53 0.52 0.33 0.23 0.45 0.56 0.48 0.49 0.51 0.56 0.43 0.22 0.18 0.23 0.04 0.34 0.34 0.36 0.51 0.513
Margin Stability 0.95 0.95 0.94 0.95 0.95 0.95 0.94 0.95 0.95 0.96 0.95 0.95 0.96 0.96 0.96 0.97 0.98 0.99 0.98 0.99 0.988
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 1.00 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.85 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.02 0.07 0.09 0.12 0.11 0.02 -0.01 -0.10 -0.24 -0.26 -0.26 -0.21 -0.05 0.05 0.05 0.09 -0.32 -0.34 -0.74 -0.86 -0.865
Gross Margin Trend -0.03 -0.02 -0.00 0.00 0.01 0.00 0.01 -0.00 -0.03 -0.02 -0.02 -0.02 -0.01 -0.01 0.00 0.01 0.02 0.01 0.01 0.01 0.006
FCF Margin Trend -0.13 -0.04 0.02 -0.22 -0.26 -0.19 -0.17 -0.15 -0.02 -0.07 -0.13 -0.00 0.03 0.07 0.19 0.17 0.11 0.13 0.12 0.10 0.100
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.09 -0.73 -0.67 12.21 8.26 1.41 0.95 0.64 0.18 0.23 0.42 0.41 0.60 0.60 0.07 0.06 0.06 0.01 -0.00 -0.01 -0.006
FCF/OCF 4.54 -0.48 0.01 1.17 1.13 1.31 1.42 1.67 2.67 2.16 1.66 1.61 1.52 1.53 4.41 5.59 2.21 11.86 -11.61 -7.25 -7.250
FCF/Net Income snapshot only 0.044
CapEx/Revenue 3.9% 4.0% 2.6% 2.5% 2.9% 5.2% 6.7% 9.0% 10.7% 10.1% 9.7% 7.5% 6.0% 4.5% 3.5% 3.5% 3.3% 2.9% 2.8% 2.4% 2.39%
CapEx/Depreciation snapshot only 0.382
Accruals Ratio -0.04 -0.02 -0.03 0.07 0.09 0.02 -0.00 -0.04 -0.16 -0.17 -0.13 -0.12 -0.05 -0.04 -0.11 -0.09 -0.34 -0.37 -0.42 -0.46 -0.464
Sloan Accruals snapshot only 0.015
Cash Flow Adequacy snapshot only 0.121
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.07%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.5% -0.4% -0.5% -0.7% -0.71%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -0.5% -0.4% -0.5% -0.7% -0.71%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.61 1.44 0.48 0.24 0.37 0.59 0.80 0.88 0.94 0.97 1.00 1.00 0.99 0.99 1.03 0.80 0.94 0.94 0.93 1.00 1.000
Interest Burden (EBT/EBIT) 1.32 0.58 0.64 1.11 1.16 1.05 1.03 1.03 1.01 1.01 1.02 1.03 1.02 1.03 1.01 1.02 1.03 1.04 1.036
EBIT Margin 0.00 0.00 -0.06 -0.08 -0.11 -0.18 -0.18 -0.23 -0.37 -0.37 -0.34 -0.30 -0.19 -0.14 -0.14 -0.15 -0.50 -0.51 -0.47 -0.47 -0.466
Asset Turnover 0.34 0.36 0.50 0.50 0.49 0.48 0.54 0.55 0.55 0.58 0.64 0.66 0.68 0.70 0.77 0.76 0.77 0.76 0.95 0.96 0.956
Equity Multiplier 1.51 1.51 1.48 1.48 1.48 1.48 1.36 1.36 1.36 1.36 1.41 1.41 1.41 1.41 1.46 1.46 1.46 1.46 1.62 1.62 1.622
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.77 $-0.24 $-0.34 $-0.10 $-0.22 $-0.96 $-1.37 $-1.80 $-3.04 $-3.35 $-3.06 $-2.61 $-1.71 $-1.28 $-1.40 $-1.11 $-4.27 $-4.30 $-3.92 $-4.27 $-4.27
Book Value/Share $11.41 $10.81 $12.11 $12.08 $12.04 $11.99 $10.87 $10.90 $10.84 $10.82 $9.10 $8.71 $8.64 $8.62 $7.70 $7.67 $7.58 $7.53 $3.94 $3.93 $3.60
Tangible Book/Share $-0.35 $-0.33 $4.06 $4.05 $4.04 $4.02 $2.69 $2.70 $2.68 $2.68 $1.70 $1.63 $1.61 $1.61 $1.67 $1.67 $1.65 $1.64 $1.75 $1.74 $1.74
Revenue/Share $6.58 $6.50 $8.64 $8.52 $8.36 $8.20 $8.32 $8.54 $8.55 $8.97 $8.75 $8.61 $8.85 $9.06 $9.19 $9.10 $9.00 $8.86 $8.84 $8.85 $8.85
FCF/Share $-0.33 $-0.08 $0.00 $-1.46 $-2.05 $-1.77 $-1.87 $-1.92 $-1.46 $-1.69 $-2.14 $-1.72 $-1.56 $-1.18 $-0.42 $-0.39 $-0.54 $-0.28 $-0.22 $-0.19 $-0.22
OCF/Share $-0.07 $0.18 $0.23 $-1.25 $-1.81 $-1.35 $-1.31 $-1.15 $-0.55 $-0.78 $-1.29 $-1.07 $-1.02 $-0.77 $-0.10 $-0.07 $-0.24 $-0.02 $0.02 $0.03 $0.03
Cash/Share $1.95 $1.85 $4.25 $4.24 $4.23 $4.21 $1.41 $1.41 $1.41 $1.40 $1.64 $1.57 $1.56 $1.55 $1.12 $1.12 $1.11 $1.10 $1.60 $1.60 $1.33
EBITDA/Share $-0.44 $0.56 $0.20 $0.52 $0.24 $-0.82 $-0.83 $-1.21 $-2.41 $-2.59 $-2.29 $-1.94 $-1.03 $-0.57 $-0.65 $-0.70 $-3.87 $-3.89 $-3.55 $-3.57 $-3.57
Debt/Share $3.74 $3.55 $1.16 $1.15 $1.15 $1.14 $1.78 $1.78 $1.77 $1.77 $1.77 $1.69 $1.68 $1.67 $1.54 $1.54 $1.52 $1.51 $2.25 $2.24 $2.24
Net Debt/Share $1.79 $1.70 $-3.10 $-3.09 $-3.08 $-3.07 $0.37 $0.37 $0.37 $0.37 $0.13 $0.12 $0.12 $0.12 $0.42 $0.41 $0.41 $0.41 $0.65 $0.64 $0.64
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score -1.769
Altman Z-Prime snapshot only -5.698
Piotroski F-Score 3 4 4 2 3 2 2 2 2 3 3 4 5 5 4 4 3 2 4 5 5
Beneish M-Score -2.46 -3.00 -2.19 -2.10 -2.37 -2.35 -2.58 -3.13 -3.15 -2.89 -2.95 -2.66 -2.59 -3.54 -2.91 -4.18 -4.29 -5.26 -5.52 -5.516
Ohlson O-Score snapshot only -5.172
ROIC (Greenblatt) snapshot only -1.07%
Net-Net WC snapshot only $-0.06
EVA snapshot only $-345785000.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B
Credit Score 48.53 46.15 54.11 53.78 43.79 50.81 46.10 54.35 54.64 45.90 46.51 51.47 55.64 58.31 44.20 32.91 27.84 27.45 29.15 27.91 27.914
Credit Grade snapshot only 15
Credit Trend snapshot only -5.000
Implied Spread (bps) snapshot only 750.000
Industry Credit Rank snapshot only 16
Sector Credit Rank snapshot only 17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms